Lysosome‐associated genes ATP6V1E1 and immune response‐related genes (IL2RG, OSM, EVI2B TNFRSF1A, CXCR4, STAT5A) were significantly correlated with Aβ or Tau pathology, which may be candidate targets for AD treatment. This evidence concerns the gene MAPT and Alzheimer disease.